Related Experiment Video
Updated: Jul 14, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Silencing E1A mRNA by RNA interference inhibits adenovirus replication
1Division of Influenza and Respiratory Viruses, Center for Infectious Disease, National Institute of Health, Korea Centers for Disease Control and Prevention, Seoul, South Korea.
Small interfering RNAs (siRNAs) targeting adenovirus E1A messenger RNA (mRNA) effectively inhibited adenovirus replication. This RNA interference (RNAi) approach shows potential as a novel antiviral therapy for adenovirus infections.
Area of Science:
- Virology
- Molecular Biology
- Gene Therapy
Background:
- Adenoviruses cause significant respiratory tract infections, with limited treatment options.
- Adenovirus type 11 can cause severe complications, especially in immunocompromised individuals.
- Current treatments for adenovirus infections are insufficient, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the potential of RNA interference (RNAi) as a therapeutic strategy against adenovirus infections.
- To assess the efficacy of small interfering RNAs (siRNAs) targeting adenovirus E1A mRNA.
- To determine if inhibiting adenovirus E1A can suppress viral replication.
Main Methods:
- Utilized synthetic small interfering RNAs (siRNAs) to target adenovirus E1A.
- Employed RNA interference (RNAi) to inhibit viral gene expression.
- Quantified adenovirus E1A mRNA levels and viral replicative intermediates.
Main Results:
- Successfully reduced adenovirus E1A mRNA levels using siRNAs.
- Observed a decrease in viral replicative intermediates.
- Demonstrated that siRNA-mediated silencing of E1A mRNA inhibits adenovirus replication.
Conclusions:
- RNA interference targeting adenovirus E1A is a promising strategy for controlling adenovirus infections.
- siRNA-mediated suppression of E1A mRNA effectively inhibits viral replication.
- This approach holds potential as a novel antiviral therapy.
More Related Videos
10:22Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...